Rising Demand For Precision Medicine Propels The Growth Of Lab Automation In Drug Discovery Market Emerges as a Core Driver of the Lab Automation In Drug Discovery Market in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Lab Automation In Drug Discovery Market Through 2025?
The size of the market for lab automation in drug discovery has witnessed a consistent upward trend in the past few years. The value is predicted to increase from $6.47 billion in 2024 to $6.77 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.7%. Key factors such as the escalating complexity in drug discovery, the necessity for improved efficiency and lessened costs, burgeoning demand for high-throughput screening, surging labor charges, and the urge to hasten the timelines of drug development have been the driving forces behind the historic growth period.

What's the Projected Size of the Global Lab Automation In Drug Discovery Market by 2029?
In the forthcoming years, the market size for lab automation in drug discovery is anticipated to experience substantial growth, reaching a value of "$8.28 billion in 2029 with a compound annual growth rate (CAGR) of 5.2%. Factors contributing to this expected growth include the expansion of pharmaceutical companies' drug pipelines, the growing prominence of personalized medicine and precision therapeutics, increased focus on rare diseases and orphan drugs, and a rising demand for remote and decentralized clinical trials, along with the advent of microfluidics and lab-on-a-chip technologies. Key trends for the forecast period include the spread of adjustable and modular automation solutions, the embrace of cloud platforms for data management and collaboration, the expansion of automation in emerging markets, the emergence of virtual drug discovery firms that utilize digital technologies and automation, and the creation of universal protocols and compatible systems.

View the full report here:
https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Top Growth Drivers in the Lab Automation In Drug Discovery Industry: What's Accelerating the Market?
The surge in demand for precision medicine is forecasted to boost the expansion of laboratory automation in the drug discovery industry. Precision medicine, also referred to as personalized medicine, adopts a medical treatment and prevention strategy that considers the differences in genes, environment, and lifestyle of each individual. The acceleration of research, enhancement of experimental repeatability, and better efficiency in precision medicine and drug discovery processes brought about by lab automation leads to the development of more effective treatments and diagnostic tools tailored to individual patients. For instance, in October 2022, the Personalized Medicine Coalition (PMC), an organization based in the United States that encourages the understanding and implementation of personalized medicine, predicts that over 75,000 genetic testing products and 300 personalized medicines will be available on the market for people suffering from a variety of cancer types, rare genetic diseases, and multiple chronic and infectious diseases. Consequently, the escalating demand for precision medicine propels the expansion of laboratory automation in the drug discovery industry.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14410&type=smp

What Are the Key Trends Driving Lab Automation In Drug Discovery Market Growth?
Leading businesses in the lab automation sector of the drug discovery market are shifting their priorities towards the creation of superior solutions like rapid idea-to-data solutions in order to create a market advantage. Rapid idea-to-data solutions refer to streamlined systems or platforms that let companies or individuals promptly convert their ideas into implementable insights. For example, in April 2022, Strateos Inc., an American biotech firm, introduced a novel rapid idea-to-data solution aimed at small molecule discovery on its cloud-based lab automation service platform. This lab automation tool has been precisely created for small molecule discovery in the field of drug creation. The Strateos Cloud Lab Automation-as-a-Service Platform, accessible on-demand and scalable, incorporates connected robotic automation consisting of 23 work cells and hundreds of apparatuses. This platform facilitates the acceleration of the process from early lead generation to lead optimization by employing a software design that permits users to contrive their preferred compounds in the cloud and have them automatically created and examined using an array of methods including cellular, biochemical, and structure-activity relationship (SAR) assessments.

What Are the Main Segments in the Lab Automation In Drug Discovery Market?
The lab automation in drug discovery market covered in this report is segmented -

1) By Type: Automated Liquid Handlers, Automated Plate Handlers, Robotic Arms, Automated Storage And Retrieval Systems, Other Types
2) By Component: Instruments, Software, Services
3) By Application: High-Throughput Screening, Compound Management, Sample Preparation, Other Applications
4) By End-User: Biotechnology And Pharmaceutical Industries, Research Institutes, Other End-Users

Subsegments:
1) By Automated Liquid Handlers: Automated Liquid Handlers, Multi-Channel Pipettes, Reagent Dispensing Systems, Automated Titrators, Liquid Handling Workstations
2) By Automated Plate Handlers: Automated Plate Handlers, Microplate Stacker Systems, Plate Transportation Systems, Plate Sorting Systems
3) By Robotic Arms: Robotic Arms, Cartesian Robots, SCARA Robots, Articulated Robots, Delta Robots
4) By Automated Storage And Retrieval Systems (ASRS): Automated Storage and Retrieval Systems (ASRS), Vertical Lift Modules (VLM), Automated Guided Vehicles (AGVs), Carousel-Based Systems, High-Density Storage Systems
5) By Other Types: Automated Sample Preparation Systems, Laboratory Information Management Systems (LIMS), Microarray Processors, Automated Screening Systems

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=14410&type=smp

Which Top Companies are Driving Growth in the Lab Automation In Drug Discovery Market?
Major companies operating in the lab automation in drug discovery market are Thermo Fisher Scientific Inc., Abbott Diagnostics, Roche Holdings Inc., Beckman Coulter, Siemens Healthineers, Becton Dickinson and Company, Agilent Technologies Inc., PerkinElmer Inc., Endress+Hauser, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., QIAGEN, Beckhoff Automation GmbH & Co. KG, Eppendorf AG, Tecan Group Ltd., Brooks Automation Inc., Hamilton Company, AbCellera Biologics Inc., Hudson Robotics Inc., OpenTrons Labworks Inc., Quanterix Corporation, The Technology Partnership, HighRes Biosolutions Inc., Biosero Inc., Peak Analysis and Automation Ltd., Aurora Biomed Inc., Arctoris, Inveox GmbH, Synthace, Synchron Lab Automation

Which Regions Will Dominate the Lab Automation In Drug Discovery Market Through 2029?
North America was the largest region in the lab automation in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14410

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.